These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36197916)

  • 1. The role of environmental enteric dysfunction in the pathogenesis of Schistosoma mansoni-associated morbidity in school-aged children.
    Araújo Fiuza J; Colt S; Gambogi de Ornellas L; Ferreira Matoso L; Gazzinelli A; Friedman JF; Corrêa-Oliveira R
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010837. PubMed ID: 36197916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia.
    Bajiro M; Dana D; Ayana M; Emana D; Mekonnen Z; Zawdie B; Garbi A; Kure A; Zeynudin A
    Parasit Vectors; 2016 Oct; 9(1):560. PubMed ID: 27772528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
    Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
    BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
    Abudho BO; Ndombi EM; Guya B; Carter JM; Riner DK; Kittur N; Karanja DMS; Secor WE; Colley DG
    Am J Trop Med Hyg; 2018 May; 98(5):1397-1402. PubMed ID: 29532768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.
    Tweyongyere R; Naniima P; Mawa PA; Jones FM; Webb EL; Cose S; Dunne DW; Elliott AM
    PLoS Negl Trop Dis; 2013; 7(10):e2501. PubMed ID: 24147175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
    Koukounari A; Donnelly CA; Sacko M; Keita AD; Landouré A; Dembelé R; Bosqué-Oliva E; Gabrielli AF; Gouvras A; Traoré M; Fenwick A; Webster JP
    BMC Infect Dis; 2010 Jul; 10():227. PubMed ID: 20670408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy.
    Koukounari A; Fenwick A; Whawell S; Kabatereine NB; Kazibwe F; Tukahebwa EM; Stothard JR; Donnelly CA; Webster JP
    Am J Trop Med Hyg; 2006 Aug; 75(2):278-86. PubMed ID: 16896133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Praziquantel Treatment and
    Berhanu MS; Atnafie SA; Ali TE; Chekol AA; Kebede HB
    Ethiop J Health Sci; 2022 May; 32(3):631-640. PubMed ID: 35813666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
    Gouvras AN; Kariuki C; Koukounari A; Norton AJ; Lange CN; Ireri E; Fenwick A; Mkoji GM; Webster JP
    Acta Trop; 2013 Nov; 128(2):309-17. PubMed ID: 23313322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.
    Wilson S; Vennervald BJ; Kadzo H; Ireri E; Amaganga C; Booth M; Kariuki HC; Mwatha JK; Kimani G; Ouma JH; Muchiri E; Dunne DW
    Trop Med Int Health; 2007 Dec; 12(12):1442-9. PubMed ID: 18076550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
    Khayeka-Wandabwa C; Zhou G; Magak NG; Choge JK; Kemei WK; Makwali JA; Karani LW; Kisavi MP; Ndulu JV; Anjili CO
    Exp Parasitol; 2019 Sep; 204():107728. PubMed ID: 31348915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of school-based preventive chemotherapy strategies for sustaining the control of schistosomiasis in Côte d'Ivoire: Results of a 5-year cluster randomized trial.
    Ouattara M; Diakité NR; Yao PK; Saric J; Coulibaly JT; Assaré RK; Bassa FK; Koné N; Guindo-Coulibaly N; Hattendorf J; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008845. PubMed ID: 33449924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
    Barakat R; El Morshedy H
    Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
    Kemal M; Tadesse G; Esmael A; Abay SM; Kebede T
    BMC Res Notes; 2019 Apr; 12(1):211. PubMed ID: 30953565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal schistosomiasis among preschool and school-aged children in a rural setting near Alexandria: initiative for elimination.
    Allam AF; Salem A; Elsheredy A; Dewair MM; Ibrahim HS; Farag HF; Hagras NA; Shehab AY
    Trop Med Int Health; 2021 Jun; 26(6):632-639. PubMed ID: 33576107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel.
    Ahmed AM; El Tash LA; Mohamed EY; Adam I
    J Helminthol; 2012 Jun; 86(2):228-32. PubMed ID: 21729382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.